S297: ASSESSING THE COST-EFFECTIVENESS OF LONG-TERM PROPHYLAXIS STRATEGIES IN VON WILLEBRAND DISEASE

• M. Wilson,
• G. Castaman,
• G. Escolar,
• W. Miesbach,
• S. Santos,
• S. Yan

Affiliations

M. Wilson

1 RTI Health Solutions, Research Triangle Park, NC, United States of America

G. Castaman

2 Center for Bleeding Disorders, Careggi University Hospital, Florence, Italy

G. Escolar

3 Department of Hematopathology, Centre Diagnostic Biomedic, Hospital Clinic, Barcelona, Spain

W. Miesbach

4 Haemophilia Centre, Medical Clinic II, Institute of Transfusion Medicine, Goethe University Hospital, Frankfurt am Main

S. Santos

5 CSL Behring, Hattersheim am Main, Germany

S. Yan

6 CSL Behring, King of Prussia, PA, United States of America